Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dospray is a branded intranasal spray used for the symptomatic treatment of persistent allergic rhinitis, providing local relief of nasal symptoms such as congestion, rhinorrhea, sneezing, and itching. It is formulated as a nasal spray for topical delivery to the nasal mucosa, where its active ingredient(s) exert anti‑inflammatory and antiallergic effects to reduce mucosal edema and allergic symptoms. Detailed public information on its exact active ingredient(s), developer, and global regulatory status is limited; available data derive primarily from a post‑registration observational study evaluating its effectiveness and safety in persistent allergic rhinitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dospray.